Ignite Creation Date:
2024-05-05 @ 11:08 AM
Last Modification Date:
2024-10-26 @ 9:02 AM
Study NCT ID:
NCT00002167
Status:
COMPLETED
Last Update Posted:
2005-06-24
First Post:
1999-11-02
Brief Title:
Photodynamic Therapy Clinical Trial For Cutaneous AIDS-Related Kaposis Sarcoma Study Summary
Sponsor:
Clinical Solutions
Organization:
NIH AIDS Clinical Trials Information Service
Study Overview
Official Title:
Photodynamic Therapy Clinical Trial For Cutaneous AIDS-Related Kaposis Sarcoma Study Summary
Status:
COMPLETED
Status Verified Date:
1999-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To determine the objective tumor response and remission rate of AIDS-related Kaposis sarcomas KS following a single dose of tin ethyl etiopurpurin SnET2 followed by photodynamic therapy PDT To determine the systemic and local toxicity and morbidity safety profile of SnET2-PDT
Detailed Description:
All patients receive a single dose of SnET2 and are randomized to receive either PDT light treatment or no light treatment control group Patients are assessed prior to and at 4 12 and 24 weeks following treatment and are followed for 7 months
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: